Abstract
As the biopharmaceutical industry matures and embraces process intensification methodologies allied to the emergence of newer personalized medicines, a key constant is the regulatory need to purify products that satisfy the criteria of safety, quality, and efficacy in each batch of released product destined for clinical use. Downstream processing operations and in particular chromatographic separations continue to play a key role in manufacturing strategies with the industry being well served by commercially available resins that provide different options to purify a particular target molecule of interest. In recent years, mixed-mode chromatography, a technique based on multimode interactions between ligands and proteins, had attracted much attention. This short review will discuss the concept and benefit of mixed-mode chromatography in purification strategies and specifically look at its application in the purification of IgG subtype monoclonal antibodies, a key product class in today’s industry.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Walsh G (2014) Biopharmaceutical benchmarks. Nat Biotechnol 32:992–1000
Yang O, Prabhu S, Ierapetritou M (2019) Comparison between batch and continuous monoclonal antibody production and economic analysis. Ind Eng Chem Res 58(15):5851–5863
Zhu J (2012) Mammalian cell protein expression for biopharmaceutical production. Biotechnol Adv 30:1158–1170
McAtee AG, Templeton N, Young JD (2014) Role of Chinese hamster ovary central carbon metabolism in controlling the quality of secreted biotherapeutic proteins. Pharm Bioprocess 2:63–74
Rouiller Y, Perilleux A, Vesin MN, Stettler M, Jordan M, Broly H (2014) Modulation of mAb quality attributes using microliter scale fed-batch cultures. Biotechnol Prog 30:571–583
Ling WL (2015) Development of protein-free medium for therapeutic protein production in mammalian cells: recent advances and perspectives. Pharm Bioprocess 3:215–226
Chen C, Wong HE, Goudar T (2018) Upstream process intensification and continuous manufacturing. Curr Opin Chem Eng 22:191–198
Strube J, Ditz R, Kornecki M, Huter A, Schmidt H, Thiess S, Zobel-Roos S (2018) Process intensification in biologics manufacturing. Chem Eng Process: Process Intensif 133:278–293
Gerstweiler L, Bi J, Middelberg APJ (2021) Continuous downstream bioprocessing for intensified manufacture of biopharmaceuticals and antibodies. Chem Eng Sci 231:116272
Zydney AL (2016) Continuous downstream processing for high value biological products: a review. Biotechnol Bioeng 113:465–475
Khanal O, Lenhoff AM (2021) Developments and opportunities in continuous biopharmaceutical manufacturing. MAbs 13(1):1903664
Fisher AC, Kamga M-H, Agarabi C, Brorson K, Lee SL, Yoon S (2019) The current scientific and regulatory landscape in advancing integrated continuous biopharmaceutical manufacturing. Trends Biotechnol 37:253–267
Strickley RG, Lambert WL (2021) A review of formulations of commercially available antibodies. J Pharm Sci 110:2590–2698
Danielsson Å (2018) Affinity chromatography. In: Jagschies G, Lindskog E, Lacki K, Galliher P (eds) Biopharmaceutical processing: development, design and implementation of manufacturing processes. Elsevier, Amsterdam, pp 367–378
Grönberg A (2018) Ion exchange chromatography. In: Jagschies G, Lindskog E, Lacki K, Galliher P (eds) Biopharmaceutical processing: development, design and implementation of manufacturing processes. Elsevier, Amsterdam, pp 379–399
Eriksson KO (2018) Hydrophobic interaction chromatography. In: Jagschies G, Lindskog E, Lacki K, Galliher P (eds) Biopharmaceutical processing: development, design and implementation of manufacturing processes. Elsevier, Amsterdam, pp 401–407
Bolton G, Mehta K (2016) The role of more than 40 years of improvement in protein A chromatography in the growth of the therapeutic antibody industry. Biotechnol Prog 32:1193–1202
Geng XD, Ke CY, Chen G, Liu P, Wang F, Zhang HQ, Sun X (2009) On-line separation of native proteins by two-dimensional liquid chromatography using a single column. J Chromatogr A 1216:3553–3562
Yang Y, Geng X (2011) Mixed-mode chromatography and its applications to biopolymers. J Chromatogr A 1218:8813–8825
Zhang K, Liu X (2016) Mixed-mode chromatography in pharmaceutical and biopharmaceutical applications. J Pharm Biomed Anal 128:73–88
Kaleas KA, Tripodi M, Revelli S, Sharma V, Pizarro SA (2014) Evaluation of a multimodal resin for selective capture of CHO-derived monoclonal antibodies directly from harvested cell culture fluid. J Chromatogr B 969:256–263
Zhang Y, Lingli C, Wang Y, Li Y (2019) Processing of high-salt-containing protein A eluate using mixed-mode chromatography in purifying an aggregation-prone antibody. Protein Expr Purif 164:105458
Brekkan E (2018) Multimodal chromatography. In: Jagschies G, Lindskog E, Lacki K, Galliher P (eds) Biopharmaceutical processing: development, design and implementation of manufacturing processes. Elsevier, Amsterdam, pp 409–419
Rassi ZE, Horvath C (1986) Tandem columns and mixed-bed columns in high-performance liquid chromatography of proteins. J Chromatogr A 359:255–264
Wolters DA, Washburn MP, Yates JR (2001) An automated multidimensional protein identification technology for shotgun proteomics. Anal Chem 73:5683–5690
Walshe M, Kelly MT, Smyth MR, Ritchie H (1995) Retention studies on mixed-mode columns in high-performance liquid chromatography. J Chromatogr A 708:31–40
Zhao G, Dong XY, Sun Y (2009) Ligands for mixed-mode protein chromatography: principles, characteristics and design. J Biotechnol 144:3–11
Brenac Brochier V, Chabre H, Lautrette A, Ravault M-N, Couret A, Didierlaurent P, Moingeon P (2009) High throughput screening of mixed-mode sorbents and optimisation using pre-packed lab-scale columns for the purification of the recombinant allergan rBet v 1a. J Chromatogr B 877:2420–2427
Hjelm H, Hjelm K, Sjöquist J (1972) Protein A from Staphylococcus aureus. Its isolation by affinity chromatography and its use as an immunosorbent for isolation of immunoglobulins. FEBS Lett 28:73–76
Shukla AA, Hubbard B, Tressel T, Guhan S, Low D (2007) Downstream processing of monoclonal antibodies-application of platform approaches. J Chromatogr B 848:28–39
Arakawa T, Kita Y, Sato H, Ejima D (2009) MEP chromatography of antibody and Fc-fusion protein using aqueous arginine solution. Protein Expr Purif 63:158–163
Cytiva Application Note 28-9078-92: two-step purification of monoclonal IgG1 from CHO cell culture supernatant. Available from https://www.cytivalifesciences.com
Cytiva Application Note 28-9078-89: optimisation of loading conditions on Capto™ adhere using design of experiments. Available from https://www.cytivalifesciences.com
Cytiva Application Note 29-0373-49 AA: polishing of monoclonal antibodies using Capto™ MMC ImpReS in bind and elute mode. Available from https://www.cytivalifesciences.com
Cytiva Application Note 29-0373-49 AA: polishing of monoclonal antibodies using Capto™ adhere ImpReS in bind and elute mode. Available from https://www.cytivalifesciences.com
Sartorius Product Data Sheet: HEA and PPA HyperCel resins. Mixed-mode Chromatography for Protein Separation Available from https://www.sartorius.com
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Milne, J.J. (2023). Mixed-Mode Chromatography and Its Role in Monoclonal Antibody Purification. In: Loughran, S.T., Milne, J.J. (eds) Protein Chromatography. Methods in Molecular Biology, vol 2699. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3362-5_2
Download citation
DOI: https://doi.org/10.1007/978-1-0716-3362-5_2
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-3361-8
Online ISBN: 978-1-0716-3362-5
eBook Packages: Springer Protocols